חזרה לתוצאות החיפוש

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Sickle Cell Disease Vaso-occlusive Crisis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Univ. of California, San Francisco Health Care, Oakland, California, United States

  • University of California Irvine, Orange, California, United States

    Contact: Study coordinator (Use Central Contact)

  • Golisano Children's Hospital, Fort Myers, Florida, United States

    Contact: Study coordinator (Use Central Contact)

  • The Foundation for Sickle Cell Disease, Hollywood, Florida, United States

    Contact: Study coordinator (Use Central Contact)

  • University of Louisville Hospital, Louisville, Kentucky, United States

  • University of Maryland, Baltimore, Maryland, United States

    Contact: Study coordinator (USE CENTRAL Contact)

  • Detroit Medical Center, Detroit, Michigan, United States

  • Henry Ford Health System, Detroit, Michigan, United States

    Contact: Study coordinator (Use Central Contact)

  • Mount Sinai Medical Center, New York, New York, United States

    Contact: Study coordinator (USE CENTRAL CONTACT)

  • Jacobi Medical Center, The Bronx, New York, United States

    Contact: Study coordinator (Central Contact)

  • East Carolina University, Greenville, North Carolina, United States

  • University of Cincinnati, Cincinnati, Ohio, United States

    Contact: Study coordinator (Use Central Contact)

  • The Ohio State University, Columbus, Ohio, United States

    Contact: Study coordinator (USE CENTRAL CONTACT)

  • University of Pittsburgh, Pittsburgh, Pennsylvania, United States

  • Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

  • Virginia Commonwealth University, Richmond, Virginia, United States

  • Hacettepe Universitesi, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Central Contact)

  • Istanbul Universitesi, Istanbul, Turkey (Türkiye)

    Contact: Study coordinator (Central Contact)

  • Özel Acibadem Adana Hastanesi, Seyhan, Turkey (Türkiye)

    Contact: Study coordinator (Central Contact)
מובילי המחקר

  • Study Director

    CSL Behring

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)